The lack of awareness will come as a surprise to the UK public with a quarter of us giving ourselves a solid 7 out of 10 when asked to rate our health but with just 38% of us having been tested previously for Type 2 diabetes , the majority of people are unaware of their risk.
Type 2 diabetes can strike at any time but a common misconception is that you are mainly at risk when you are over 50 years old. However, according to LloydsPharmacy’s data from the past twelve months , one in five of those who had a high or very high risk of Type 2 diabetes were aged under 50, indicating that people may need to consider their risks sooner than they think.
In total, one in 14 people tested by LloydsPharmacy in 2016 had a high or very high risk of developing Type 2 diabetes in the next 10 years.
A lack of awareness about the symptoms also exists in the UK. When questioned, 45% of people failed to correctly identify increased thirst as a symptom and just 16% knew that frequent episodes of thrush is a symptom. 33% incorrectly identified sugar cravings as a symptom of Type 2 diabetes and 8% incorrectly identified body odour as a symptom.
LloydsPharmacy pharmacist Varun Bitra commented, “Type 2 diabetes commonly hits around middle age but it can develop in people who are much younger, even children. If left untreated it can lead to serious health problems, but when identified early and correctly managed people can maintain their health well and even reverse the progression of the condition. LloydsPharmacy can help you to identify your risk by completing a simple questionnaire and, if necessary, measure your blood pressure and taking a very small finger-prick sample of blood to measure your blood glucose level.”
LloydsPharmacy is on a hunt to find TheMissingMillion with a roadshow around the country, where they are offering free Type 2 diabetes screenings and the chance to get expert advice on managing your health to reduce your risk. Visit letstalkdiabetes.co.uk for more information.
Otherwise people are encouraged to pop into their local LloydsPharmacy and ask for the free Type 2 diabetes screening in store.
LloydsPharmacy and their contribution managing Type 2 diabetes
In 2003 LloydsPharmacy was the first national pharmacy network to offer free screening for Type 2 diabetes.
Over 1.5 million people have been screened for Type 2 diabetes at LloydsPharmacy since 2003 and 4,012 checks were completed in 2016.
The Type 2 diabetes screening is for people who may be at risk of developing the condition. It is characterised by what is known as insulin resistance. This is where the body does not effectively respond to the insulin produced, as a result blood sugar levels become too high. lloydspharmacy.com/diabetes.
LloydsPharmacy has around 1,800 pharmacies across the UK. These are based predominantly in community and health centre locations and include 277 LloydsPharmacy in Sainsbury’s branches. The company employs over 19,000 staff and dispenses more than 150 million prescription items annually.
Lloydspharmacy Online Doctor have helped treat over 1.3 million patients in the UK. They offer a safe and easy way to consult with a registered clinician online, and convenient same-day collection in LloydsPharmacy or discreet delivery.
LloydsPharmacy is part of the Celesio Group; a leading international pharmaceutical wholesale and retail pharmacy company.
With strong brands and about 39,000 employees, the group is active in 13 European countries (thereof with own operations in ten countries; Celesio manages operations in two countries and participates in a joint venture in one country). Every day, the company serves over 2 million customers – at more than 2,100 pharmacies of its own, at about 300 managed pharmacies and at over 5,700 participants in the brand partnership schemes. With 110 own and seven managed wholesale branches in Europe, McKesson Europe supplies more than 55,000 pharmacies and hospitals every day with up to 130,000 pharmaceutical products.
McKesson Corporation, San Francisco, USA, is the majority shareholder in Celesio AG. The company acquired more than 75 percent of Celesio AG shares in February 2014. McKesson provides solutions that include pharmaceutical and medical-surgical supply management, healthcare information technology, and business and clinical services.
McKesson is a Fortune-500 company and currently ranking #5.